Jacobs Levy Equity Management
CELL

Jacobs Levy Equity Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Jacobs Levy Equity Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-97,321
Closed -$47.7K – 1099
2023
Q2 		$47.7K Sell
97,321
-358,601
-79% -$293K ﹤0.01% 953
2023
Q1 		$529K Sell
455,922
-891,152
-66% -$1.63M ﹤0.01% 794
2022
Q4 		$3.61M Sell
1,347,074
-37,980
-3% -$100K 0.02% 452
2022
Q3 		$3.96M Buy
1,385,054
+778,043
+128% +$3.31M 0.03% 439
2022
Q2 		$3.02M Buy
+607,011
New +$3.18M 0.02% 513

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management's CELL Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 97,321 shares — an estimated $47.7K sold.

Jacobs Levy Equity Management first reported a position in CELL in Q2 2022 and held it in 5 quarters. The position peaked at $3.96M in Q3 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Jacobs Levy Equity Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 97,321 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $47.7K.
  • Jacobs Levy Equity Management first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Jacobs Levy Equity Management's PhenomeX Inc. Common Stock position peaked at $3.96M in Q3 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.